Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 13.13M | $360.0M | 20.44% | +5.17M | 2026-06-30 |
| Orbis Allan Gray Ltd | 11.37M | $312.0M | 17.70% | -1.56M | 2026-06-30 |
| Deep Track Capital, LP | 8.65M | $237.0M | 13.47% | +4.99M | 2026-06-30 |
| ALLIANCEBERNSTEIN L.P. | 8.64M | $231.0M | 13.46% | -912.3K | 2026-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 6.87M | $188.0M | 10.69% | +4.40M | 2026-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4.98M | $136.0M | 7.75% | -- | 2026-06-30 |
| BlackRock, Inc. | 4.67M | $128.0M | 7.27% | +134.7K | 2026-06-30 |
| Sofinnova Investments, Inc. | 4.05M | $111.0M | 6.30% | +3.29M | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 3.52M | $96.0M | 5.48% | -896.7K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 3.51M | $96.0M | 5.46% | -- | 2026-06-30 |
